05 Compliance

The regulatory file for peanut protein peptides

Technical document 05 · Reviewed 2026-11-19 · Peanut Protein Peptides

On this page
  1. What the file has to answer
  2. European Union
  3. United States
  4. Contaminants and limits
  5. Claims and the label
  6. The document pack
  7. Checklist before the first order

Peanut protein peptides are a peanut-derived hydrolysate, and the regulatory file follows the source, the process and the destination. The specification and the certificate describe the material; the allergen statement, the mycotoxin results and the route have to be confirmed for the market where the finished product is sold. The buyer's regulatory team confirms the route; this page lists the framework and the documents.

In one line

The file follows the destination and the source: a peanut-derived peptide carries the peanut allergen declaration, a mycotoxin and contaminant file, and a route that the buyer's regulatory team confirms.

What the file has to answer

The file should settle four things: the exact material and the specification revision behind it; the lot and its certificate; the route, limits and label rules for the destination; and the change-control trigger if source, process or pack moves. A COA, a TDS and an SDS each answer a different part; none of them answers the route.

The file carries the allergen statement naming peanut, the origin record, the process description and the specification revision. Keep the documents versioned, and name any missing statement before the order rather than at the port. The material name matters: “peanut protein peptides” or “hydrolysed peanut protein” names the source; “plant peptide” does not.

European Union

In the EU, the file sits under Regulation (EC) No 178/2002 and the food information rules in Regulation (EU) No 1169/2011. Annex II of the food information rules lists peanut and products thereof, so the ingredient has to appear in the ingredient list and be emphasised; hydrolysis does not lift that duty. A “may contain peanut” statement is a cross-contact control, not a substitute for the ingredient declaration.

The novel-food question, under Regulation (EU) 2015/2283, turns on the specific history of use and the production process. Peanut itself has a food history; that does not by itself decide the status of a peptide fraction made by a particular route. For supplements, the relevant instruments are Directive 2002/46/EC, Regulation (EU) 2023/915 on contaminants and Regulation (EC) No 1924/2006 on claims, as of this review. Great Britain and Northern Ireland are checked as two files: GB uses the retained texts, while Northern Ireland stays under the EU framework.

United States

In the US, peanut is a major food allergen under FALCPA and must be declared in the ingredient list or in a “contains” statement; 21 CFR 101 sets the label rules. A supplement facility works to 21 CFR 111, a conventional food facility to 21 CFR 117; the buyer confirms the site certificate.

The dietary-ingredient route depends on the basis the supplier relies on: a documented history of use, a GRAS basis, or a new dietary ingredient notification under 21 U.S.C. 350b. The supplier should identify the basis and the document behind it; the buyer checks that both cover the finished product. State rules such as California Proposition 65 may add a lead calculation.

Contaminants and limits

A contaminant result on the drum is not the end of the calculation; the finished-product dose and category decide the exposure. The table is a starting point, not a substitute for the current text.

References to confirm for peanut protein peptides, by market
ParameterEU referenceUS referenceWhat the file shows
Peanut allergenAnnex II: declare and emphasiseMajor food allergen under FALCPALabel, COA and allergen statement
Aflatoxin B12.0 µg/kg for peanuts used as food or an ingredientCovered by the total action levelLot result, method and sampling plan
Total aflatoxin4.0 µg/kg for the same category20 µg/kg action level for peanut productsLot result and sampling plan
Lead3.0 mg/kg in food supplementsNo federal supplement-specific limit; state rules applyResult and finished-product calculation
Cadmium1.0 mg/kg in food supplementsNo federal supplement-specific limitResult and category check
Mercury0.10 mg/kg in food supplementsNo federal supplement-specific limitResult and method
ArsenicNot harmonised; member state rules applyNo federal supplement-specific limitThe agreed limit and method

Aflatoxin is the peanut-specific line. It is not in the catalog panel, so it belongs in the agreed specification, with a sampling plan: contamination is not evenly distributed, and a small sample can miss a hot spot. Ochratoxin A belongs where the destination sets a limit. Heavy-metal limits for a food supplement and for an ingredient destined for a food category are not the same calculation; confirm which applies.

Claims and the label

A disease claim is not available for this ingredient in the EU, the US or the UK. “Hypoallergenic” and “allergen-free” are not available for a peanut-derived peptide: hydrolysis reduces some proteins, but the source and the declaration remain. A “peptide” claim about rapid absorption is a health or structure/function claim and needs its own basis in the destination; the ingredient page does not carry it.

Protein claims are nutrition claims calculated on the finished product. In the EU, “source of protein” is 12% of the energy from protein and “high protein” is 20%; in the US, “good source” is 10% of the daily value and “excellent source” is 20%. “Plant-based” is true but does not change the allergen duty. The brand's regulatory reviewer signs off the final wording for the market.

The document pack

  • Specification with the revision, protein factor and basis, and peptide HPLC cut-off.
  • COA with results and methods, and the peanut allergen statement on the COA.
  • Aflatoxin results and the sampling plan.
  • Origin, non-GMO, residual-solvent and carrier declarations.
  • SDS and the site's GMP, HACCP or ISO certificates.
  • Halal or kosher statement where required; third-party report where the buyer asks.
  • Allergen changeover and cleaning validation statement for shared lines.

Version numbers on the document list do more for an audit than a folder of undated PDFs. Where a statement is missing, name the gap before the order.

Checklist before the first order

  1. Is the exact peanut peptide and its route confirmed for the destination?
  2. Is peanut declared on the label, the COA and the allergen statement?
  3. Are aflatoxin and heavy-metal results converted to the finished-product dose?
  4. Is the protein or peptide claim arithmetic shown and allowed?
  5. Does the file carry COA methods, the specification revision and the site certificates?
  6. Is the allergen changeover and cleaning control documented?

The catalog specification is published on the peanut protein peptide product page; the COA page walks through the certificate; the identity page covers the analytical evidence; the EU and US summaries set out the framework; the quality page explains the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation